HomeOpen Access NewsInfectious Diseases

Infectious Diseases

Collaboration is crucial for future pandemic preparedness

Pandemic preparedness: A new report has sounded the alarm on the urgent need to address global disparities and foster interdisciplinary cooperation to effectively prepare for and respond to future pandemics.

UK Government and CureVac partnership to tackle COVID-19 virus variants

The UK Government and vaccine manufacturer CureVac have partnered to rapidly develop new vaccines in response to new COVID-19 virus variants.

97.2% of in-person COVID test results returned the next day

NHS Test and Trace turnaround times continue to rise as 97.2% of in-person COVID test results are returned the next day.

Over 10 million people receive COVID-19 vaccine

UK reaches significant milestone as more than 10 million people receive the first dose of the COVID-19 vaccine.

Clinical trial looks into mixing different COVID-19 vaccines

A world-first clinical trial looking into mixing different COVID-19 vaccine doses has been backed by £7 million of government funding.

Orthodox Jew’s have one of the highest COVID-19 infection rates

A new study has found that the UK strictly-Orthodox Jewish community experience one of the highest infection rates of COVID-19 throughout 2020.

South African COVID-19 variant found in UK

Additional testing has been deployed across the UK after a COVID-19 variant originally identified in South Africa has been found .

COVID-19 spike proteins could evolve against immune responses

A new study suggests that COVID-19 spike proteins could evolve to disguise themselves from the human immune system.

Scientists use immune system to predict likelihood of long COVID

Cambridge researchers have published their findings on how the immune system could be an early clue for the later development of severe or long COVID.

76% of COVID-19 patients still have one symptom, after six months

While long COVID is slowly becoming more understood, ordinary COVID-19 patients are experiencing lasting effects - scientists discovered that 76% of people have atleast one recurring symptom, six months after the original illness.

Infection prevention and control (IPC) for COVID-19 focus

Two divisions of Active Care Group – Christchurch Group and Remeo – discuss the importance of  infection prevention and control in the healthcare sector in light of COVID-19.

UK brings in Tier 4 restrictions for South East and London

As of midnight tonight (20 December), London and the South East will enter strict Tier 4 restrictions - which includes no household mixing over Christmas, and no commuting to work.

British company launches fast-acting antimicrobial coating that destroys coronavirus

Here, we learn about a British company launching a fast-acting antimicrobial coating that destroys coronavirus.

LumiBio: COVID-19 infection, prevention and control

Kate Edwards, Director of LumiBio, highlights what we need to know about COVID-19 infection, prevention and control (IPC)

A modern approach to hand hygiene training

SureWash, a CPD certified hand hygiene training company has been helping healthcare facilities globally with the fight against COVID-19. Founder and CTO, Dr Gerard Lacey tells us about their technology and what comes next for the company.

Removal of inflammatory ‘evil humors’ – the key to treating COVID-19 complications?

Phillip P. Chan, MD, PhD, Chief Executive Officer of CytoSorbents Corporation (NASDAQ: CTSO), discusses the use of CytoSorb, a broad-spectrum blood purification technology to treat cytokine storm and hyperinflammation in critically ill COVID-19 patients.

FebriDx: Rapid patient triage test and COVID-19

Here, we discover that FebriDx® rapid point of care triage can help prevent the spread of infection and improve patient streaming.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders